Real-time enrollment status for this lymphangioleiomyomatosis clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:22 AM UTC
| NCT Number | NCT01799538 |
| Recruiting Status | Recruiting |
| Condition | Lymphangioleiomyomatosis |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT01799538 is currently recruiting participants. This phase1 study for lymphangioleiomyomatosis is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01799538 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01799538 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.